MyBioGate: Your Gateway to China: Capital, Market, and More
–
Apply for Pitch & Match now, you will get an extra opportunity of online pitch!
Participants registered in Hamburg Pitch & Match before October 21 will receive an online pitch opportunity on October 29, and participants of San Francisco may join the online pitch in December (TBD).
More than 40% of the online audience are directors and CEOs. Don’t miss out the unprecedented chance to present your company in front of the leading investors in addition to the onsite audience!
More than 40% of the online audience are directors and CEOs. Don’t miss out the unprecedented chance to present your company in front of the leading investors in addition to the onsite audience!
–
| Featured Audiences (Previous Events) |
 |
| Qiming Venture Partners was founded in China in 2006 and has over $4 billion in total assets under management. In January 2017, Qiming launched Qiming USA, focused on early-stage healthcare opportunities in the United States and Europe. Situated in the major life science hubs of Cambridge, San Francisco Bay Area and Seattle, we invest in highly disruptive platforms and products addressing significant unmet medical needs, driven by passionate and committed teams with the depth and experience to succeed. |
 |
| GuoQian Medical Technology (Suzhou) Co., Ltd. is jointly established by Dr. Zhang Xu and other six experts of “The Thousand Talents Plan” in the medical field together with Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences and senior experts in investment and finance have jointly established a professional equity investment institution |
 |
| Chaperone Investment is an Angel fund focusing on life science and medical technology startups. The current AUM is 30M USD. |
 |
| MSA is a venture fund with over US$1b under management, focused on investing in AI, genomics, mobility, and SaaS companies. |
 |
| Founded in 2010, Lang Sheng Investment Group Co., Ltd (LSI) is an A-B round focus fund targeting investments on Healthcare and TMT (data-enabled). LSI now manages four funds with total AUM of RMB 1.3 billion and it has captured unicorns such as Ankon and CapitalBio, out of 30 investee companies. |
